Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that they will work together to develop clinical applications of ...
Hosted on MSN
Japan's iPS Cell Breakthroughs Are Reshaping Regenerative Medicine and Parkinson's Treatment
“It is a significant achievement that we have been able to confirm improvement in patients’ symptoms,” Director of Kyoto University’s Center for iPS Cell Research and Application (CiRA) Jun Takahashi ...
TOKYO & PALO ALTO, Calif.--(BUSINESS WIRE)--Heartseed Inc. ("Heartseed"), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure and I Peace Inc. ("I Peace"), a ...
Leading GMP cell therapy CDMO I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that it has successfully generated human induced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results